POPULARITY
Categories
47 episodes with approaches
41 episodes with approaches
60 episodes with approaches
21 episodes with approaches
80 episodes with approaches
27 episodes with approaches
38 episodes with approaches
38 episodes with approaches
26 episodes with approaches
29 episodes with approaches
38 episodes with approaches
24 episodes with approaches
38 episodes with approaches
53 episodes with approaches
15 episodes with approaches
23 episodes with approaches
17 episodes with approaches
19 episodes with approaches
10 episodes with approaches
16 episodes with approaches
17 episodes with approaches
18 episodes with approaches
17 episodes with approaches
11 episodes with approaches
17 episodes with approaches
17 episodes with approaches
11 episodes with approaches
19 episodes with approaches
8 episodes with approaches
10 episodes with approaches
15 episodes with approaches
8 episodes with approaches
8 episodes with approaches
8 episodes with approaches
14 episodes with approaches
7 episodes with approaches
7 episodes with approaches
13 episodes with approaches
9 episodes with approaches
10 episodes with approaches
8 episodes with approaches
12 episodes with approaches
7 episodes with approaches
12 episodes with approaches
16 episodes with approaches
16 episodes with approaches
8 episodes with approaches
7 episodes with approaches
33 episodes with approaches
17 episodes with approaches
10 episodes with approaches
8 episodes with approaches
6 episodes with approaches
6 episodes with approaches
In this episode Ole Schmiedel discusses Mounjaro, a new weight loss drug, with a focus on its mechanism of action, practical use, side effects, nutritional considerations, and long-term safety. The conversation provides insights into how Mounjaro differs from previous GLP-1 receptor agonists, expected weight loss outcomes, and the importance of monitoring patients while on the medication.
In Luke 19:28–40, Jesus demonstrates through His triumphal entry that His rightful kingship calls His followers to recognize Him, proclaim His glory, and respond with faithful obedience. I. The King Orchestrates His Own Entrance (vv.28–35) A. Jesus draws near to Jerusalem. (vv. 28–29) B. Jesus instructs his disciples. (vv. 30–31) C. Jesus's disciples obey. (vv. 32–35) II. The King Receives Messianic Praise (vv.36–38) A. The road is prepared before Him. (v. 36) B. The multitude rejoices loudly. (v. 37) C. The King is publicly proclaimed. (v. 38) III. The King Confronts Religious Resistance (vv.39–40) A. The Pharisees demand silence. (v. 39) B. The King declares His praise inevitable. (v. 40)
RIP: Lou Holtz WBC Begins NHL Trading Deadline Approaches
Since 2011, when I thought I would try school bus driving as a part time job, I never had this dy in mind. A few hours a day expanded. The days of the week increased. The wages went up. But the toxic environment stayed. Always short of drivers. Awkward hires with limited people skills. And a school system that could care less what the bus drivers said. Student write-ups that went nowhere. Bullying in it's many forms continued. Some routes with kids who were always unruly and disrespectful. Now I can rest. I tried my best for more than a dozen years.
Nick is joined by Jane Mangan to canter through the latest racing news. As Cheltenham approaches fast, Nick catches up with Gigginstown's Eddie O'Leary about some of the key hopefuls for the week, including Brighterdaysahead, Turners'-bound Ballyfad, Favour de Champdou, Storm Heart and the bumper trio. Plus, Derek O'Connor on his two big rides Jeriko du Reponet and It's on the Line. Also today, the return of Point to Pointing on the podcast withTattersalls and Ben Atkins, while Neil Channing has his say on Andrew Rhodes and the landscape he leaves behind at the Gambling Commission, and Nick talks to RMG Marketing Director Clive Cottrell about the organisation's partnership with the Teenage Cancer Trust
Nick is joined by Jane Mangan to canter through the latest racing news. As Cheltenham approaches fast, Nick catches up with Gigginstown's Eddie O'Leary about some of the key hopefuls for the week, including Brighterdaysahead, Turners'-bound Ballyfad, Favour de Champdou, Storm Heart and the bumper trio. Plus, Derek O'Connor on his two big rides Jeriko du Reponet and It's on the Line. Also today, the return of Point to Pointing on the podcast withTattersalls and Ben Atkins, while Neil Channing has his say on Andrew Rhodes and the landscape he leaves behind at the Gambling Commission, and Nick talks to RMG Marketing Director Clive Cottrell about the organisation's partnership with the Teenage Cancer Trust
8:30 - Jeremy and Joe speak more on free agent options for the Bills at wide receiver.
The US-Israeli war with Iran is approaching its fifth day and the death toll continues to climb with one human rights group reporting over a thousand civilian deaths in Iran. US Admiral Brad Cooper says America's military has deployed more than 50,000 troops to the region and destroyed 17 Iranian ships so far in the operation dubbed "Epic Fury". While this conflict began with US-Israeli strikes against Iran, several other countries have now been dragged into the war. CNN's Matthew Chance spoke to Lisa Owen from Beirut.
Brandon and Tyson break down Jets vs Blackhawks and go over the Jets plan ahead of Friday's Trade Deadline Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com for information about our collection and use of personal data for advertising.
Four years after its founding, St. Louis' Office of Violence Prevention is still working to address the causes of violence — and trying to stop it before it happens. In November, the city named the office's new director, Marvin Teer, Jr. A former judge and prosecutor, Teer shares some of his experiences from three decades in the criminal justice system. He also addresses the likely impact of losing access to millions of dollars in federal funding when the American Rescue Plan Act expires at the end of the year. Teer says the change will affect more than 40 programs: “Our mission will go on,” he says, “but just in a very limited, or, at least in a reduced manner.” Joining Teer is James Watson, director of the nonprofit Show Me Peace, who discusses examples of how violence can be interrupted and how OVP creates an “ecosystem” of programs addressing its root causes.
In orthopedic IR, confidence comes from exposure. It's all about getting those reps in. In this BackTable MSK Brief, host Kavi Krishnasamy interviews Dr. Brandon Key from the Medical College of Wisconsin about implementing bone stabilization and fixation in interventional radiology for pathologic and non-pathologic fractures. The doctors discuss key barriers which include limited training exposure and operational inefficiencies that discourage adoption. However, they highlight the evolving technology, vendor toolsets, and growing multidisciplinary collaboration that are mitigating these barriers. The discussion expands to cover trauma-related consults from orthopedic surgery, indications and evolving applications of the IlluminOss device, screw types and preferences, and the capabilities of the Flow-FX cement-delivery device. Episode Outline 00:00 - Introduction 00:57 - The Delay in Take-Off of Bony Fixation and Stabilization at the Trainee Level 03:10 - Meaningful Multidisciplinary Momentum 05:35 - Treatment of Pathologic Fractures in the Orthopedic IR Space 09:17 - Considerations for Trauma and Fragility Cases 16:09 - Patient Prep and Approach 18:05 - Final Thoughts Resources Dr. Brandon Key, MD https://www.linkedin.com/in/brandon-key-md-367a01310/ IlluminOss https://illuminoss.com/us Flow-FXhttps://flow-fx.net/products/
"This remains an active investigation and will continue until Nancy Guthrie is located or all leads have been exhausted," the Pima County Sheriff's Department stated in a February 27 press release.Advertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy
Dr. Martin Noland of Grace Lutheran-San Mateo, CA The Latest Edition of Logia JournalThe post Comparing the Lutheran and Calvinist Approaches to Scripture – Dr. Martin Noland, 3/2/26 (0611) first appeared on Issues, Etc..
How do you think of God when you pray? Last week we began a new series on prayer. This week we continue exploring the theological dynamics of approaching God as King, Father, and Shepherd while also discussing an overview of the 5 Levels of Prayer in harmony with the Life Model stages of maturity. From infancy to our elder years, we have expanding capcacity to engage in prayer on our own and in community. Our goal with this series is to encourage you to deepen your prayer life and explore various approaches to your relationship with God. By the end of this series, we'll have walked through three approaches to your prayer time that we hope you find impactful and refreshing. You can start practicing now with the free "Listening Prayer Starter Kit" pdf in a link below. Thank you for joining us – father-daughter duo Marcus Warner and Stephanie Warner – on the trail to a deeper walk with God!
Welcome to the Oncology Brothers podcast! In this episode, we dived into the evolving frontline treatment landscape for triple-negative breast cancer (TNBC). Listen us on: Spotify: https://open.spotify.com/show/31BXhY9FM4gPWG10WgE11o Follow us on social media: • X/Twitter: https://twitter.com/oncbrothers • Instagram: https://www.instagram.com/oncbrothers • Website: https://oncbrothers.com/ Join us as we welcomed Dr. Sherene Loi, a leading breast medical oncologist from Australia, to discuss the challenges of treating TNBC and the exciting new treatment options available. We explored the significance of PD-L1 scoring in metastatic TNBC, the implications of recent trials like ASCENT-04, and the potential of antibody-drug conjugates (ADCs) such as sacituzumab govitecan and datopotamab deruxtecan. Key topics included: • The role of PD-L1 positivity in treatment decisions • Insights from the ASCENT-04 trial and its findings • Common side effects associated with sacituzumab and strategies for management • The future of immunotherapy and ADCs in TNBC treatment Whether you're a healthcare professional or someone interested in the latest advancements in oncology, this episode is packed with valuable information and clinical pearls. Don't forget to subscribe for more insightful discussions on cancer treatment! #TNBC, #PDL1positive, #ASCENT04, #Immunotherapy, #OncBrothers
8:30 - Jeremy and Joe discuss what moves we could expect from the Bills as the new league year and legal tampering period are coming up.
Ramos grew up in Bellevue and is the associate professor in the Department of Health Promotion of the UNMC College of Public Health and is also involved in the School of Public Health's Center for Reducing Health Disparities. Her research interests have an emphasis on Intercultural communication, cultural competency, and coalition-building, and she was given UNMC's distinguished scientist award in 2025.
With one week left in the Big 12 basketball regular season, Heartland College Sports' Pete Mundo analyzes who is rising at the right time of the season, and who is on the struggle bus?! Meantime, which teams are just hanging on for dear life?!Subscribe to Heartland College Sports for independent Big 12 coverage all season long — basketball, football, realignment, and more.
Jacob Bridgeman wins The Genesis. The Florida Swing approaches major events.
In this episode, as first heard on WEEI, Jaffe & Razor break down the Bruins' first game back after the Olympic break. They discuss the big win fueled by an outstanding performance from Korpisalo, how the team continues to find ways to win, key lineup decisions moving forward, and how the Bruins should approach the trade deadline as the stretch run begins. Take a second to visit some of our great sponsors! Visit Fazenda at fazendacoffe.com Visit Sparx Hockey at www.sparxhockey.com Visit Copeland Auto Group at www.countoncopeland.com Visit Sunset Lake CBD at www.sunsetlakecbd.com Learn more about your ad choices. Visit megaphone.fm/adchoices
Share your Field Stories!Welcome back to Environmental Professionals Radio, Connecting the Environmental Professionals Community Through Conversation, with your hosts Laura Thorne and Nic Frederick! On today's episode, we talk with Amy Jacobs, The Nature Conservancy, Chesapeake Bay Director, about Wetland Restoration, Agricultural Water Quality, and Chesapeake Bay Conservation. Read her full bio below.Help us continue to create great content! If you'd like to sponsor a future episode hit the support podcast button or visit www.environmentalprofessionalsradio.com/sponsor-form Showtimes:1:40 - Our favorite Airbnb experiences6:10 - Interview with Amy Jacobs Starts!12:39 - Jacobs Conservation Efforts20:02 - Approaches to the Watershed26:32 - Jacobs paddle boarding hobbyPlease be sure to ✔️subscribe, ⭐rate and ✍review. This podcast is produced by the National Association of Environmental Professions (NAEP). Check out all the NAEP has to offer at NAEP.org.Connect with Amy Jacobs at https://www.linkedin.com/in/amy-jacobs-a945041a7/Guest Bio:Amy brings over 30 years of experience in conservation, dedicating her career to making a significant impact in the Chesapeake Bay and surrounding landscapes. She began her journey with The Nature Conservancy, assessing the condition of wetlands in the Nanticoke Watershed. Amy then took a position with the Delaware Department of Natural Resources and Environmental Control, where she built a Wetland Assessment and Monitoring Program. In 2012, she returned to The Nature Conservancy for the mission and to advance restoration in the Chesapeake Bay. Amy has a proven track record of leading large-scale conservation programs, securing funding, and fostering impactful partnerships. From working to restore over 3,500 acres of floodplains along the Pocomoke River to working with private agribusiness to establish the MidAtlantic 4R Nutrient Stewardship Association that has advanced over 150,000 acres of improved farmland management in the Chesapeake region, she is passionate about driving impact on the ground. Amy holds a bachelor's degree in forestry and wildlife from Virginia Tech and a master's degree in Environmental Forest Biology from the State University of New York and Syracuse University.In her free time Amy enjoys traveling with her family, standup paddleboarding, yoga, raising funds for local food pantries, and being a groupie to her husband's band.Music CreditsIntro: Givin Me Eyes by Grace MesaOutro: Never Ending Soul Groove by Mattijs Muller Support the showThanks for listening! A new episode drops every Friday. Like, share, subscribe, and/or sponsor to help support the continuation of the show. You can find us on Twitter, Facebook, YouTube, and all your favorite podcast players.
The Colorado Avalanche are heading into the NHL trade deadline with big questions after a frustrating loss. On this episode of Off Ice, Jesse Montano and Meghan Angley break down everything surrounding the Avs right now — from the game itself to the bigger picture decisions facing the front office.
The NFL 2025-2026 season is over, and there is a long list of players who are potentially going to be cut for both health and salary cap purposes. There are plenty of talking points as we wrap up the season, including who may, or may not, get get cut this offseason. That's where the For Your Viewing Pleasure podcast comes in where hosts Jeff Hartman and Wesley Coleman talk about the latest news and notes in the NFL. This podcast is a part of the Pro Football Insiders. Learn more about your ad choices. Visit megaphone.fm/adchoices
In this episode of Derms and Conditions, host James Q. Del Rosso, DO, welcomes Lisa Swanson, MD, to explore how acne management continues to evolve and how newer topical therapies can be integrated thoughtfully from the outset. They begin with Dr Swanson highlighting an important clinical reality: acne is presenting at increasingly younger ages, prompting earlier conversations about skin care routines and long-term strategies. At the same time, dermatologists now have several truly novel topical options, an uncommon development in acne therapeutics over the past decade. Using a typical adolescent patient as a reference point, she then outlines the range of options she reviews in clinic: foundational topical regimens (retinoids, benzoyl peroxide combinations, clascoterone, topical minocycline foam, or fixed triple combinations), selective short courses of oral antibiotics, consideration of oral probiotics based on emerging data, and hormonal approaches in appropriate female patients. She emphasizes tailoring mechanisms when combining therapies; for example, pairing hormonal therapy with a topical that offers a complementary pathway. Dr Del Rosso revisits the 4 pillars of acne pathophysiology, highlighting androgen-driven sebum production as an upstream contributor. This leads to a focused discussion on clascoterone as the first topical androgen receptor inhibitor and how targeting sebum early may alter lesion development. Both clinicians stress that clascoterone is best viewed as foundational rather than adjunctive therapy, emphasizing the importance of setting realistic expectations on time to peak efficacy. The conversation also covers tolerability, barrier considerations, twice-daily adherence, and admixture data with common topical agents. Clinical pearls include setting early follow-ups to reinforce adherence, aligning office staff messaging, and using shared decision-making to balance patient priorities like oil control and pore appearance with mechanistic treatment goals. Tune in to the episode to hear real strategies for initiating acne therapy with intention, integrating newer topicals early, and guiding patients toward regimens that are both physiologically sound and sustainable in everyday practice.
What's up everyone! This week I'm sitting down with Chris Burandt—yeah, THE Chris Burandt. X Games gold medalist, backcountry snowmobile legend, and someone I've looked up to since the original Schooled videos dropped. If you grew up watching extreme snowmobiling, you know exactly who this guy is. But what a lot of people don't know is that Chris is also a serious elk hunter who's been chasing bulls with a bow for over 25 years. This conversation is incredible because we dive deep into what it takes to master a craft—whether that's throwing backflips at X Games or stalking a giant public land bull for 20 straight days. Chris breaks down his journey from hating hunting as a kid (sitting in the cold while his dad napped) to becoming obsessed with bowhunting after reading Cam Hanes' book and having his mind blown on his very first day in the woods. We talk about the parallels between high-level snowmobiling and elk hunting, why both require you to get comfortable being uncomfortable, and how Chris's ability to read terrain from a snowmobile gives him a massive advantage when hunting big country. He also gets brutally honest about the mistakes he's made—including missing a giant bull at 46 yards after spending an entire season prepping for that exact moment, and what he learned from it. One of the most fascinating parts of this episode is Chris talking about spending 20 days hunting ONE bull on public land in Colorado without making a single call until the moment he shot. We break down the chess match, the patience required, and whether he should've been more aggressive. This is a masterclass in strategic hunting, mental preparation, and the sacrifice required to be a true 10-percenter. If you want to hear from someone who's mastered pressure situations at the highest level and is now applying that same intensity to archery elk hunting, this episode is for you. Chris is real, humble, and just getting started in this game—and that makes his perspective incredibly valuable. Sponsors Tricer - I run Tricer gear, and for good reason. They just dropped the updated AD and BC tripods with new TriTech technology—smaller diameter center post, packs down smaller, couple inches shorter, and a cleaner top. Drew is constantly innovating and pushing the limits on what a tripod system can do. From tripods to bino mounts, panheads, and bipods, Tricer makes gear that's fast, light, and simple. Head to tricer.com and use code TRO to save 10% at checkout. Stone Glacier - If you're a mountain hunter, you know gear weight matters. Every ounce counts when you're grinding up and down mountains all day. Stone Glacier was built by Kurt, a legit mountain sheep hunter who designed minimalist, lightweight gear that actually holds up in the nastiest conditions. No gimmicks, no BS—just mountain gear built by mountain hunters. Whether it's packs, sleeping bags, or shelters, they've got you covered. Check them out at stoneglaciergear.com and use code TRO at checkout. OnX Hunt - We didn't have an OnX ad in this episode, but if you're not using OnX, you're missing out on the most essential hunting tool out there. Detailed maps, property boundaries, offline access, and now weather data that takes topography into account. Become an Elite member at onxmaps.com and use code TRO to save 20%. Timestamps 00:00 - Intro: Meeting a childhood hero 04:15 - Why Chris kept elk hunting separate from his snowmobile career 08:30 - Growing up hating rifle hunting with his dad 12:20 - Reading Cam's book and the first day bowhunting (running at a bull) 18:45 - The path from beginner to deadly: Steps 1-5 24:10 - Signing up for Mountain Tough and learning you have to train 28:50 - Giving up three hunting seasons to guide for experience 33:20 - Why 10% of hunters kill 90% of the elk 37:40 - Reading terrain like a snowmobile rider vs. a hunter 42:15 - Hunting one mountain vs. bouncing around 46:30 - The 2023 hunt: Drawing a dream tag and going all in 51:00 - Missing the giant bull at 46 yards and what he learned 55:20 - The mental difference between X Games pressure and elk hunting 59:45 - 20 days hunting one bull without calling 1:03:30 - Should he have been more aggressive? Tactics breakdown 1:06:15 - Advice for new bowhunters and closing thoughts Three Key Takeaways Guiding for Experience is Underrated - Chris gave up three of his own hunting seasons to guide on private land, not for the money, but for the reps. Being around elk every single day, getting multiple "at bats" in a season instead of hoping for one opportunity on public land, accelerated his learning curve by years. If you want to get better fast, find ways to be around elk as much as possible—even if it means helping friends on their hunts or volunteering to pack out. Control the Controllables, Then Trust the Process - Chris went all-in preparing for his 2023 dream tag—quit drinking, worked out every day, scouted relentlessly, dialed his gear—but he neglected shooting practice. He had a 46-yard shot on a giant bull and missed because he split the wrong pins. His lesson: You can do 99% of it right and still fail if you don't master the fundamentals. Shooting your bow consistently, year-round, is non-negotiable if you want to capitalize when the moment comes. Reading Terrain Like a Snowmobiler Gives You a Massive Edge - Chris's ability to see mountains on a macro level (from snowmobiling hundreds of miles and connecting drainages) gives him a huge advantage over hunters who think micro. Most hunters pick a trailhead and hunt one drainage. Elite hunters understand how the entire mountain system works—where elk can move between basins, what routes they'll take, and how to cut them off. If you want to be a 10-percenter, stop thinking small and start hunting the whole mountain.
The NFL 2025-2026 season is over, and there is a long list of players who are potentially going to be cut for both health and salary cap purposes. There are plenty of talking points as we wrap up the season, including who may, or may not, get get cut this offseason. That's where the For Your Viewing Pleasure podcast comes in where hosts Jeff Hartman and Wesley Coleman talk about the latest news and notes in the NFL. This podcast is a part of the Pro Football Insiders. Learn more about your ad choices. Visit megaphone.fm/adchoices
“The reality is that there are power differentials between a student, a junior scholar and a full professor, or between a medical assistant, a patient, and a physician. But recognizing those power dynamics, if you are in a position of power, really using your privilege, your position as a gatekeeper to speak up and intervene or to give platform to folks that may have less access to power to intervene.”-Khadijah AmeenDrs. Khadijah Ameen and Collins Airhihenbuwa share their work on how to expand how we think about bystandersand perpetrators of racial violence, and how bystander behavioral approaches can be used to intervene. They bring in antiracism frameworks such as the Public Health Critical Race Praxis and the PEN-3 Cultural Model to illustrate their points using some antiracism bystander intervention scenarios.This episode references the article “Expanding Bystander Behavioral Approaches to Address Racial Violence in Health Research, Pedagogy, and Practice” by Khadijah Ameen and Collins Airhihenbuwa.
-Apparently, Texans RB Joe Mixon had Surgery?!? -March Madness PREVIEW as Friend of the Show, Rob Dauster Joins LIVE! -Is it Time for the Rockets to Put MORE Responsibility on Plate of Jabari??
Cristina Saura Manich, MD, PhD - First-Line Treatment of HER2-Positive Metastatic Breast Cancer: Could Investigational Approaches Improve on Current Standard of Care?
The integration of Artificial Intelligence (AI) into post-injury rehabilitation is transforming recovery paradigms by enabling personalized, adaptive, and efficient rehabilitation pathways tailored to individual patient needs. This podcast reviews the current advances in AI applications that facilitate assessment, monitoring, and optimization of rehabilitation programs following injuries. Through machine learning algorithms, wearable sensors, and predictive analytics, AI enhances the precision of therapy plans, tracks patient progress in real-time, and predicts recovery trajectories. The discussion includes the benefits of AI-driven rehabilitation, including improved functional outcomes, reduced recovery times, and increased patient engagement. It also addresses challenges such as data privacy, algorithmic bias, and integration with clinical workflows. 1. Transforming recovery paradigms Traditional post‑injury rehab relies on periodic in‑person assessments, therapist intuition, and standardized protocols that only partially account for individual variability. AI is shifting this model toward: Continuous, data‑driven care: Instead of snapshots in clinic, rehab can be informed by near real‑time streams of kinematic, physiological, and behavioral data from wearables, smart devices, and robot interfaces. Dynamic adaptation: Therapy intensity, task difficulty, and exercise selection can be automatically adjusted based on ongoing performance, fatigue, and recovery trends, rather than fixed schedules. Precision rehabilitation: Algorithms can identify which patients are likely to respond to specific interventions (e.g., constraint‑induced movement therapy vs robotics) and tailor plans accordingly. This moves rehabilitation from a "one‑size‑fits‑many" paradigm toward precision, context‑aware therapy, analogous to precision oncology but focused on function and participation. 2. Assessment, monitoring, and optimization AI for assessment Sensor‑based movement analysis: Machine learning models process accelerometer, IMU, EMG, and pressure data to quantify gait symmetry, joint kinematics, balance, and fine motor control with higher resolution than visual observation alone. Automated scoring: AI can approximate or support standardized scales (e.g., Fugl‑Meyer, Berg Balance Scale) by mapping sensor features or video-derived pose estimates to clinical scores, reducing inter‑rater variability and saving clinician time. Continuous monitoring Home and community tracking: Wearable and ambient sensors enable monitoring of daily steps, walking speed, arm use, posture, and adherence to exercises outside the clinic, feeding rich longitudinal datasets into AI models. Real‑time alerts: Algorithms can detect abnormal patterns—such as increased fall risk, reduced limb use, or signs of over‑exertion—and flag the clinician or adjust digital therapy content automatically. Optimization and decision support Predictive models: Using historical data, AI can forecast functional gains, plateau points, or risk of complications (e.g., falls, readmission), supporting individualized goal‑setting and resource allocation. Reinforcement learning and "digital twins": Emerging work in neurorehabilitation treats rehab as a sequential decision problem, using model‑based reinforcement learning and patient "digital twins" to recommend optimal timing, dosing, and progression of interventions over weeks to months. 3. Technologies: ML, wearables, analytics Machine learning algorithms: Supervised ML classifies movement quality (normal vs compensatory), detects exercise type from sensor streams, and estimates clinical scores. Unsupervised learning clusters patients into phenotypes (e.g., gait patterns after stroke), revealing subgroups that respond differently to certain therapies. Reinforcement learning and contextual bandits explore which therapy adjustments yield the best long‑term functional outcomes for a given individual. Wearable sensors and robotics: Inertial sensors, EMG, pressure insoles, and exoskeleton sensors capture high‑frequency movement and muscle activity data during training. Robotic devices (upper‑limb exoskeletons, gait trainers) coupled with AI can modulate assistance, resistance, or task difficulty in real time based on performance and predicted fatigue. Predictive and prescriptive analytics: Predictive analytics estimate trajectories (e.g., time to independent walking, expected upper‑limb function) to inform shared decisions with patients and families. Prescriptive analytics recommend therapy intensity, modality mix, and scheduling to maximize functional gains under resource constraints. 4. Benefits: outcomes, efficiency, engagement Improved functional outcomes: Studies report better motor recovery, gait quality, and ADL performance when AI‑assisted training is used—especially when robotics and intelligent feedback are involved. Reduced recovery time and resource use: More precise dosing and earlier identification of non‑responders can reduce ineffective sessions, shorten time to key milestones, and support safe earlier discharge with robust remote follow‑up. Increased adherence and engagement: AI‑driven digital rehab platforms use gamification, adaptive difficulty, and personalized feedback to keep patients engaged in home programs, improving adherence compared to static paper instructions. Support for clinicians: Instead of replacing therapists, AI can offload repetitive measurement tasks, highlight concerning trends, and offer data‑driven suggestions, allowing clinicians to focus on relational, motivational, and complex decision‑making aspects of care. 5. Challenges and ethical considerations Data privacy and security: Rehab AI often relies on continuous collection of sensitive motion, physiological, and sometimes audio/video data, raising questions about consent, storage, secondary use, and breach risk. Approaches like federated learning and on‑device processing are being explored to reduce centralization of identifiable data while still enabling model training. Algorithmic bias and fairness: If training data under‑represent older adults, women, certain racial/ethnic groups, or people with severe disability, AI models may misestimate performance or risk for those groups, potentially widening disparities in rehab access and outcomes. Ongoing auditing, diverse datasets, and participatory design with patients and clinicians are needed to ensure equitable performance. Integration with clinical workflows: Many AI tools are developed in research settings and are not yet seamlessly integrated into EHRs, scheduling systems, or therapist documentation workflows. Poorly integrated tools risk adding documentation burden or "alert fatigue," reducing adoption. Successful implementations co‑design interfaces with frontline therapists and physicians. Regulation, liability, and trust: It remains unclear in many jurisdictions how to regulate adaptive rehab algorithms (as medical devices, clinical decision support, or wellness tools) and who is liable when AI‑informed plans cause harm. Transparent, explainable models and clear communication to patients about the role of AI are critical for maintaining trust. 6. Case studies and emerging trends Remote and hybrid digital rehabilitation: AI‑driven platforms providing home‑based stroke, orthopedic, or Parkinson's rehab with clinician dashboards are improving adherence and extending care beyond brick‑and‑mortar clinics. Collaborative AI for precision neurorehabilitation: Frameworks combining patient‑clinician goal setting, digital twins, and reinforcement learning exemplify "collaborative AI" that augments rather than replaces therapists. Multimodal personalization: Integration of movement data, EMG, heart rate, sleep, and self‑reported pain/fatigue is enabling more nuanced adaptation to daily fluctuations in capacity. Conversational AI for education and coaching: Early work is assessing tools like ChatGPT as low‑risk supports for exercise education and motivation, though they are not yet precise enough to replace professional plan design AI is moving rehab toward patient‑centered, continuously adapting, and data‑rich care, but realizing this promise depends on addressing privacy, bias, workflow, and regulatory challenges in partnership with clinicians and patients.
Trouble with bowel or bladder function? It might be time to partner with a specialist. In this episode of BackTable OBGYN, hosts Dr. Amy Park and Dr. Mark Hoffman are joined by Dr. Shannon Wallace and Dr. Anna Spivak, experts from the Cleveland Clinic specializing in pelvic floor disorders. They dive into the complex world of combined colorectal and urogynecological issues, discussing the importance of a multidisciplinary approach to treat conditions such as rectal prolapse, constipation, and incontinence. --- SYNPOSIS The conversation covers detailed diagnostic methods like manometry and defecography, various surgical options, and the crucial role of pelvic floor physical therapy in patient recovery. They also provide insights into setting up effective multidisciplinary clinics and emphasize the need for teamwork and administrative support in delivering optimal patient care. This episode is a valuable resource for both specialists and generalists aiming to enhance their understanding and treatment of pelvic floor dysfunctions. --- TIMESTAMPS 01:05 - Introduction05:40 - Multi-Compartment Prolapse & Second Opinions08:14 - Pelvic Floor Compartments Explained10:36 - When Internal Prolapse Becomes Surgical11:56 - Incomplete Emptying, Splinting, Fragmentation & Leakage16:55 - Fluoro vs MRI and When to Order It23:47 - Anorectal Manometry26:56 - Physical Therapy, Biofeedback, Meds, Injections, & Motility Workup29:08 - Robotic Mesh Repairs vs Vaginal/Perineal Approaches34:43 - When (and Why) to Consider Biologics36:46 - Resection Rectopexy38:10 - Treating Ehlers-Danlos syndromes (EDS) & Eating Disorders42:55 - Pelvic Floor PT After Surgery and Recovery Timelines47:29- Perineal Prolapse Repairs (Altemeier vs Delorme)49:53 - Symptom Improvement vs Retraining the 'New Normal'52:20 - Fecal Incontinence & Sacral Neuromodulation57:08 - Diarrhea-Driven Incontinence58:56 - Building a Multidisciplinary Pelvic Floor Program01:04:04 - Conclusion --- RESOURCES Pelvic Floor Disorders Consortium (American Society of Colon & Rectal Surgeons) https://fascrs.org/Web/Web/My-ASCRS/Education/Pelvic-Floor-Disorders-Consortium.aspx
In this episode of The People Dividend Podcast, host Mike Horne sits down with Scott Hutcheson, a bio-social scientist and author, to explore the concept of biohacking leadership. They discuss how biological signals influence leadership effectiveness, the importance of understanding behavioral signals, and practical applications of leadership biodynamics. Scott emphasizes the role of keystone leaders in shaping organizational ecosystems and shares techniques for leaders to enhance their effectiveness through experimentation and refinement of their approaches. Key Points: Scott Hutcheson introduces biohacking leadership, focusing on using biological signals to enhance leadership effectiveness by shaping trust and collaboration. Leadership is an experimental process where leaders should adjust their behavioral signals based on feedback to achieve better outcomes. Biodynamic channels, including warmth, competence, and gravitas, are essential for leaders to connect, contribute, and create shared value. Keystone leadership is compared to keystone species, where certain leaders can significantly influence organizational culture regardless of their position. Leaders are advised to create space for reflection and narrate their thinking to improve decision-making and team performance. Links: Learn more about Mike Horne on Linkedin Email Mike at mike@mike-horne.com Learn More About Executive and Organization Development with Mike Horne Twitter: https://twitter.com/mikehorneauthor Instagram: https://www.instagram.com/mikehorneauthor/, LinkedIn Mike's Newsletter: https://www.linkedin.com/newsletters/6867258581922799617/, Schedule a Discovery Call with Mike: https://calendly.com/mikehorne/15-minute-discovery-call-with-mike Learn More about Scott Hutcheson: https://scotthutcheson.com/ #peopledividendpodcast #podcastepisode #podcastrecommendations #Leadership #Biohacking #TeamPerformance #OrganizationalCulture #LeadershipDevelopment
Living with the End in Mind: Dr. Pyle emphasizes the importance of preparing for the inevitable. It’s not about being morbid; it’s about ensuring better days today by planning for tomorrow. In this episode of "Next Steps 4 Seniors: Conversatoins on Aging, host Wendy Jones welcomes Dr. Pamela Pyle, internal medicine physician and author of "Anticipating Heaven," to discuss end-of-life care. They explore the importance of preparation, advanced care planning, and meaningful family conversations about aging and death. Dr. Pamela Pyle shares practical tips for navigating the healthcare system, the value of tools like Five Wishes, and the role of nurses as advocates. The episode emphasizes living with the end in mind to ensure peace and clarity for families and loved ones during life’s final stages. Key Points: Navigating the Healthcare System: Learn the right questions to ask and steps to take before a crisis hits. Did you know the hospital your loved one is taken to might not be the one you expect? Preparation is key! The Role of Nurses: Nurses are invaluable advocates. They often have more time to provide insights and can be a great resource, especially during quieter times. Recording Conversations: Don’t hesitate to record medical conversations. It’s your right, and it helps ensure you don’t miss any critical information. Family Conversations: Dr. Pyle shares her unique approach to discussing end-of-life wishes with family. She even turned it into a birthday celebration! These conversations are crucial and can be a gift to your loved ones. Advanced Care Planning: Only 30% of Americans complete an advanced care plan. Tools like Five Wishes make it easier and more heartfelt. It’s a simple, affordable way to ensure your wishes are known and respected. Every week brings two ways to grow: Tuesdays dive into the physical next steps with real-life guidance for seniors and families, and Fridays uplift the heart with spiritual and emotional next steps—encouragement, faith, and hope for the journey ahead. Today’s episode explores the transformative power of forgiveness and its vital role in experiencing an abundant life as we age. To learn more about Next Steps 4 Seniors, contact us at 248-651-5010 or visit us online at www.nextsteps4seniors.com.Learn more : https://omny.fm/shows/next-steps-4-seniors-with-wendy-jonesSee omnystudio.com/listener for privacy information.
Itch is a common and often frustrating symptom that presents to the dermatology clinic. Adam Friedman, MD provides updates on emerging management strategies while Joe Gorelick, MSN, FNP-C shares tips for documenting itch--and its improvement. Plus, Gilly Munavalli, MD gives the skinny on GLP-1s and their effects on the face, and Brad Glick, DO discusses intralesional injections for nails.Like what you're hearing? Want to learn more about the Dermatology Education Foundation? Explore assets and resources on our website.
Chris Chavez and Preet Majithia break down a packed week of results from Levin, Toruń, Castellón, Boston, and more. Plus, a final look back at the Winter Olympics and a preview of what's ahead.– Keely Hodgkinson's world record at Levin is still reverberating. It's time to retire the “What about Athing Mu…” narrative.– Georgia Hunter-Bell ran 4:00 flat again at Levin but was left disappointed after a chaotic pacing situation.– The DQ heard ‘round the world: Theppiso Masalela of Botswana was disqualified from the 1500m in Toruń for an unsportsmanlike conduct gesture — a gun motion pointed at Azzedine Habz at the finish line.– A potential Nader vs. Hocker showdown at World Indoors.– Mondo Duplantis cleared 6.06m and debuted his new single “Feelin' Myself” performed live.– European distance runners have closed the gap on East Africans in road racing, at least in the 10K.– Oregon's DMR drama.– Parker Wolfe ran 12:59 for his first-ever sub-13 minute 5000m.– A light USA Indoors and Tokyo Marathon preview.– Bonus: Final Winter Olympics wrap.____________Hosts: Chris Chavez | @chris_j_chavez + Preet Majithia | @preet_athletics Produced by: Jasmine Fehr | @jasminefehr____________SUPPORT OUR SPONSORSUSATF: The USATF Indoor Track and Field Championships presented by Prevagen are back in New York City from February 28th to March 1st at the Ocean Breeze Athletic Complex in Staten Island. This is where legends don't just race; they punch their ticket to the world stage. The pressure is real, the margins are razor thin, and every athlete is fighting for one thing: a spot on Team USATF at the World Indoor Championships. Grab your tickets now at USATF.org/tickets and experience track and field at its absolute loudest.OLIPOP: A blast from the past, Olipop's Shirley Temple combines smooth vanilla flavor with bright lemon and lime, finished with cherry juice for that nostalgic grenadine-like flavor. One sip of this timeless soda proves some flavors never grow old. Try Shirley Temple and more of Olipop's flavors at DrinkOlipop.com and use code CITIUS25 at checkout to get 25% off your orders.
Take your personal data back with Incogni! Use code MARKDAVIS at the link below and get 60% off an annual plan: https://incogni.com/markdavisSee omnystudio.com/listener for privacy information.
Transforming CLL care: measurable residual disease (MRD) guided stopping, smart triplet selection, and next‑gen Bruton tyrosine kinase (BTKs)—practical insights. Credit available for this activity expires: 02/19/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/chronic-lymphocytic-leukemia-cll-review-combination-2026a10004ku?ecd=bdc_podcast_libsyn_mscpedu
Gregory Zuckerman examines the global race between Oxford-AstraZeneca, Pfizer-BioNTech, and J&J, emphasizing the different scientific approaches and the logistical advantages of one-shot vaccines. 6
This is the All Local 4:00 pm update for Sunday, February 22, 2026.
Accident or injury in New Jersey? Visit NJinjury.com or call (833)GO-NJ-LAWBUY OUR MERCH HEREJoin the mail bag by leaving a voicemail at: 908-67-9999-3Our personal Instagrams:SoboChomikJimmyJordanWelcome back to The Garden State, the only NJ podcast that gives you all the news you need to know this week. Thanks for tuning in once again and for supporting the podcast. If you're enjoying the show, make sure to leave us a review! We love reading those!Follow us on all our socials to keep up to date with that and everything else happening. https://linktr.ee/thegardenstate
Tensions are rising in the Oregon State Capitol as the legislative session nears the halfway mark. Republicans boycotted a floor session, a House leader resigned his post, and a Representative accused her Democratic colleague of creating a hostile working environment. And that was all just this week. How will lawmakers manage the political drama and keep their legislative priorities on track? We’ll give you the latest on the latest episode of OPB Politics Now. Find the show anywhere you get your podcasts.
theion is developing lithium-sulfur battery technology targeting 500 watt hours per kilogram in their first commercial product—nearly double today's lithium-ion cells at 270-300 Wh/kg—with an ultimate roadmap to 1,000 Wh/kg. By replacing nickel-manganese-cobalt cathodes with crystalline sulfur and graphite anodes with lithium metal, theion aims to deliver three times the energy density at one-third the cost and CO2 footprint of current batteries. In this episode of BUILDERS, we sat down with Dr. Ulrich Ehmes, CEO of theion, to discuss how a production-focused CEO is navigating the journey from TRL 3-4 to pilot line, why they're targeting electric aviation first, and how a 12-year battery industry veteran evaluates what actually constitutes a materials breakthrough. Topics Discussed: Why sulfur cathodes and lithium metal anodes enable the performance jump beyond lithium-ion The critical importance of monoclinic gamma crystalline structure for cycle life Navigating the transition from coin cells to pouch cells to industrialization Strategic decision-making on initial market entry for deep tech hardware Why process innovation in mixing and coating is required to unlock sulfur's full potential Building a China-independent supply chain using oil refining waste The 3-year development reality driven by cycling test requirements GTM Lessons For B2B Founders: Price your technology against value creation, not cost savings alone: Ulrich's market strategy centers on "markets which will pay a lot of money for super lightweight batteries"—specifically aviation applications where weight reduction directly enables business model viability. For eVTOLs, the constraint isn't battery cost but energy density; current batteries make many routes economically impossible. This is fundamentally different from cost-driven markets like consumer EVs where incremental weight savings have marginal value. Deep tech founders should map which customer segments face hard physical constraints that only your technology solves versus those seeking incremental optimization. The former will pay 3-5x premiums; the latter will demand cost parity from day one. Match CEO background to the company's primary risk: Ulrich led Leica's 600-person Portugal production facility for a decade before entering batteries, and he frames his value as "I'm a production guy...for me it's very important not to produce only one battery cell in a lab, but millions of cells in highest quality." For a battery company at TRL 3-4 moving toward industrialization, the existential risk isn't the science—it's whether you can manufacture at quality and yield. Many deep tech companies fail because PhD founders remain CEOs through manufacturing scale-up. Ulrich's hire signals that theion's board correctly diagnosed their de-risking sequence. Founders should brutally assess what will kill the company in the next 24 months and ensure the CEO's pattern recognition matches that failure mode. Seek investors where your technology is infrastructure for their thesis: theion's primary investor is "heavily invested in eVTOLs," making theion's battery technology directly relevant to multiple portfolio companies facing the same energy density constraint. This creates structural alignment on timeline expectations—eVTOL companies won't reach commercial scale before 2027-2028 anyway, matching theion's development cycle. The investor understands that battery development "takes time because always when you change a parameter, you have to cycle again to test the cells." This is radically different from a generalist VC expecting SaaS-like iteration speeds. Hardware founders should explicitly map how their technology unblocks other portfolio companies and use this to negotiate patient capital terms and strategic customer introductions. Use competitive landscape size as legitimacy signal, not differentiation: When pressed on disrupting incumbents, Ulrich immediately countered: "We are not the only company working on sulfur and this is good...there are 28 other companies out there." He then differentiated on "monoclinic gamma crystalline structure" validated by Drexel University achieving 4,000+ cycles. This is sophisticated category positioning: the 28 competitors validate that lithium-sulfur is a credible next-generation technology, while the specific crystalline approach provides technical differentiation for those who understand the chemistry. Founders should resist the urge to claim they're the only ones solving a problem in nascent categories—it raises "why hasn't anyone else tried this?" concerns. Instead, position within an emerging category and differentiate on technical approach. Communicate realistic timelines as competence signaling, not weakness: Ulrich states plainly that commercial availability is "at least the next three years" and frames this as doing "first things first and first things right." For sophisticated buyers in aviation and aerospace, compressed timelines signal naivety about certification requirements, manufacturing validation, and qualification testing. A battery company claiming 12-month commercialization would lose credibility with Boeing or Joby Aviation procurement teams who understand the actual development cycles. Deep tech founders should recognize that customer segments accustomed to long development cycles (aerospace, automotive, medical devices) interpret realistic timelines as domain expertise, while consumer/software buyers may interpret them as lack of urgency. Match timeline communication to buyer sophistication. // Sponsors: Front Lines — We help B2B tech companies launch, manage, and grow podcasts that drive demand, awareness, and thought leadership. www.FrontLines.io The Global Talent Co. — We help tech startups find, vet, hire, pay, and retain amazing marketing talent that costs 50-70% less than the US & Europe. www.GlobalTalent.co // Don't Miss: New Podcast Series — How I Hire Senior GTM leaders share the tactical hiring frameworks they use to build winning revenue teams. Hosted by Andy Mowat, who scaled 4 unicorns from $10M to $100M+ ARR and launched Whispered to help executives find their next role. Subscribe here: https://open.spotify.com/show/53yCHlPfLSMFimtv0riPyM
In this conversation, Dr. Jack Kall discusses his journey into biological dentistry, emphasizing the importance of nutrition, biocompatibility in dental materials, and the evolving landscape of dental practices. He addresses the ongoing debates surrounding fluoride and mercury fillings, highlighting recent developments and the future of biological dentistry as a mainstream practice. Want to see more of The Holistic Dentistry Show? Watch our episodes on YouTube! Do you have a mouth- or body-related question for Dr. Sanda? Send her a message on Instagram! Remember, you're not healthy until your mouth is healthy. So take care of it in the most natural way. Key Takeaways: (00:00) The Journey into Biological Dentistry (04:24) Understanding Holistic and Biological Dentistry (07:16) The Role of Biocompatibility in Dental Materials (09:47) Innovations in Dental Treatments and Technologies (12:42) The Fluoride Debate: Current Status and Perspectives (27:28) Mercury Fillings: Progress and Challenges (33:51) The Future of Biological Dentistry (45:46) Official Outro Holistic Dentistry (1).mp3 Connect With Us: AskDrSanda | YouTube BeverlyHillsDentalHealth.com | Instagram DrSandaMoldovan.com | Instagram Orasana.com | Instagram
On this episode, we define gout and describe its clinical presentations, etiologies, and underlying pathophysiology. We discuss current guidelines and evidence-based treatment strategies for managing gout. We also compare and contrast the efficacy, safety profiles, and appropriate use of acute and chronic gout therapies, lifestyle modifications, and patient monitoring strategies. Cole and I are happy to share that our listeners can claim ACPE-accredited continuing education for listening to this podcast episode! We have continued to partner with freeCE.com to provide listeners with the opportunity to claim 1-hour of continuing education credit for select episodes. For existing Unlimited (Gold) freeCE members, this CE option is included in your membership benefits at no additional cost! A password, which will be given at some point during this episode, is required to access the post-activity test. To earn credit for this episode, visit the following link below to go to freeCE's website: https://www.freece.com/ If you're not currently a freeCE member, we definitely suggest you explore all the benefits of their Unlimited Membership on their website and earn CE for listening to this podcast. Thanks for listening! If you want to support the podcast, check out our Patreon account. Subscribers will have access to all previous and new pharmacotherapy lectures as well as downloadable PowerPoint slides for each lecture. If you purchase an annual membership, you'll also get a free digital copy of High-Powered Medicine 3rd edition by Dr. Alex Poppen, PharmD. HPM is a book/website database of summaries for over 150 landmark clinical trials.You can visit our Patreon page at the website below: www.patreon.com/corconsultrx We want to give a big thanks to Dr. Alex Poppen, PharmD and High-Powered Medicine for sponsoring the podcast.. You can get a copy of HPM at the links below: Purchase a subscription or PDF copy - https://highpoweredmedicine.com/ Purchase the paperback and hardcover - Barnes and Noble website We want to say thank you to our sponsor, Pyrls. Try out their drug information app today. Visit the website below for a free trial: www.pyrls.com/corconsultrx We also want to thank our sponsor Freed AI. Freed is an AI scribe that listens, prepares your SOAP notes, and writes patient instructions. Charting is done before your patient walks out of the room. You can try 10 notes for free and after that it only costs $99/month. Visit the website below for more information: https://www.getfreed.ai/ If you have any questions for Cole or me, reach out to us via e-mail: Mike - mcorvino@corconsultrx.com Cole - cswanson@corconsultrx.com
What do you do when metastatic urothelial cancer responds dramatically to systemic therapy? In this episode of BackTable Urology, Dr. Abhinav Khanna (Mayo Clinic) speaks with host Dr. Daniel Roberson about the growing question of consolidative surgery after enfortumab vedotin plus pembrolizumab. They discuss how EV-pembro has reshaped treatment expectations, why unexpected complete or near-complete responses are prompting tumor board debates about cystectomy, and how careful multidisciplinary decision-making guides which patients may be considered for surgery. --- SYNPOSIS The conversation reviews early outcomes showing high rates of pathologic downstaging and the possibility that many patients may avoid additional systemic therapy after surgery, while emphasizing this approach is not yet standard of care. Dr. Khanna highlights coordination with medical oncology, radiology, and pathology, postoperative considerations, and the potential future role of biomarkers such as ctDNA. Ultimately, the episode underscores the need for clinical trials and thoughtful patient selection as clinicians navigate integrating surgery into an evolving systemic therapy landscape. --- TIMESTAMPS 00:00 - Introduction02:19 - The Evolution of Urothelial Carcinoma Treatment05:23 - Rationale for Consolidative Surgery12:32 - Patient Selection Criteria15:23 - Surgical Approach and Considerations23:58 - Pathologic Findings31:34 - The Role of Radiation39:38 - Biomarkers44:10 - Prospective Trials and Future Directions53:06 - Guidance for Urologists --- RESOURCES Consolidative Surgery for Advanced Urothelial Carcinoma Following Induction Enfortumab Vedotin and/or Immune Checkpoint Inhibitor Therapy: A Multicenter Analysishttps://pubmed.ncbi.nlm.nih.gov/40425390/ Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancerhttps://www.nejm.org/doi/full/10.1056/NEJMoa2312117 Standard or Extended Lymphadenectomy for Muscle-Invasive Bladder Cancerhttps://www.nejm.org/doi/abs/10.1056/NEJMoa2401497
Join this channel to get access to exclusive members only videos:https://www.youtube.com/channel/UCQTAVxA4dNBCoPdHhX9nnoQ/joinJoin Members Only On My Website. 7 day free trial. Save 25% when you choose an annual Membership plan. Cancel anytime:https://understandingrelationships.com/plansJoin Members Only on Spotify:https://podcasters.spotify.com/pod/show/coachcoreywayne/subscribeWhen to make dates after successful cold approaches.In this video coaching newsletter I discuss an email from a viewer who does lots of cold approaches and always waits 5-7 days to reach out to make dates. He says most of them don't reply. I tell him how to mix things up a little bit and to not be so robotic. He doesn't sound happy or like he's having much fun and he's frustrated he hasn't met another great girl yet.If you have not read my book, “How To Be A 3% Man” yet, that would be a good starting place for you. It is available in Kindle, iBook, Paperback, Hardcover or Audio Book format. If you don't have a Kindle device, you can download a free eReader app from Amazon so you can read my book on any laptop, desktop, smartphone or tablet device. Kindle $9.99, iBook $9.99, Paperback $29.99 or Hardcover 49.99. Audio Book is Free $0.00 with an Audible membership trial or buy it for $19.95. Here is the link to Audible to get the audiobook version:https://www.audible.com/pd/B01EIA86VC/?source_code=AUDFPWS0223189MWT-BK-ACX0-057626&ref=acx_bty_BK_ACX0_057626_rh_usHere is the link to Amazon to purchase Kindle, Paperback or Hardcover version:http://amzn.to/1XKRtxdHere is the link to the iBookstore to purchase iBook version:https://geo.itunes.apple.com/us/book/how-to-be-3-man-winning-heart/id948035350?mt=11&uo=6&at=1l3vuUoHere is the link to the iTunes store to purchase the iTunes audio book version:https://geo.itunes.apple.com/us/audiobook/how-to-be-a-3-man-unabridged/id1106013146?at=1l3vuUo&mt=3You can get my second book, “Mastering Yourself, How To Align Your Life With Your True Calling & Reach Your Full Potential” which is also available in Kindle $9,99, iBook $9.99, Paperback $49.99, Hardcover $99.99 and Audio Book format $24.95. Audio Book is Free $0.00 with an Audible membership trial. Here is the link to Audible to get the audiobook version:https://www.audible.com/pd/B07B3LCDKK/?source_code=AUDFPWS0223189MWT-BK-ACX0-109399&ref=acx_bty_BK_ACX0_109399_rh_usHere is the link to Amazon to purchase Kindle, Paperback or Hardcover version:https://amzn.to/2TQV2XoHere is the link to the iBookstore to purchase iBook version:https://geo.itunes.apple.com/us/book/mastering-yourself-how-to-align-your-life-your-true/id1353139487?mt=11&at=1l3vuUoHere is the link to the iTunes store to purchase the iTunes audio book version:https://geo.itunes.apple.com/us/audiobook/mastering-yourself-how-to-align-your-life-your-true/id1353594955?mt=3&at=1l3vuUoYou can get my third book, “Quotes, Ruminations & Contemplations” which is also available in Kindle $9,99, iBook $9.99, Paperback $49.99, Hardcover $99.99 and Audio Book format $24.95. Audio Book is Free $0.00 with an Audible membership trial. Here is the link to Audible to get the audiobook version:https://www.audible.com/pd/B0941XDDCJ/?source_code=AUDFPWS0223189MWT-BK-ACX0-256995&ref=acx_bty_BK_ACX0_256995_rh_usHere is the link to Amazon to purchase Kindle, Paperback or Hardcover version:https://amzn.to/33K8VwFHere is the link to the iBookstore to purchase iBook version:https://books.apple.com/us/book/quotes-ruminations-contemplations/id1563102111?itsct=books_box_link&itscg=30200&ct=books_quotes%2C_ruminations_%26_contemplatio&ls=1
Kouri Richins' defense says publicity has poisoned her jury pool beyond repair. But there's a detail the headlines missed — the judge already denied that motion days before the story even broke.Judge Richard Mrazik rejected the defense's second attempt to move the trial out of Summit County, finding that a fair and impartial jury can still be seated despite widespread awareness of the case. Prosecutors pointed to 830 potential jurors who said they hadn't heard of the case or hadn't followed it — nearly half the questionnaire pool. The defense's argument that only 72 viable jurors remain didn't hold up.What makes this case so well-known isn't reckless media coverage. It's the nature of the allegations themselves. A children's book about grief — written after her husband's death and before her arrest. A six-page jailhouse letter allegedly laying out fabricated testimony. Nearly $2 million in life insurance policies. And a drug source who now says under oath he never sold fentanyl at all.Richins is charged with aggravated murder in the 2022 fentanyl death of her husband Eric in Kamas, Utah. Prosecutors allege she spiked his cocktail with a fatal dose — five times the lethal amount found in his blood — after a failed attempt on Valentine's Day two weeks earlier. Her realty company allegedly owed at least $1.8 million while Eric's estate was worth roughly $5 million.Her case also appeared in a January 2026 DHS intelligence bulletin warning law enforcement about domestic partners using chemical and biological toxins to kill — seventeen documented cases since 2014 with at least eleven deaths.The defense wants this to be a story about an unfair system. But trace the notoriety back to its source and every thread leads to the same place. Kouri Richins has pleaded not guilty and is presumed innocent. Trial begins February 23rd.#KouriRichins #EricRichins #TrueCrimeToday #VenueChangeDenied #SummitCountyTrial #FentanylPoisoning #WalkTheDogLetter #JurySelection #RobertCrozier #UtahMurderTrialJoin Our SubStack For AD-FREE ADVANCE EPISODES & EXTRAS!: https://hiddenkillers.substack.com/Want to comment and watch this podcast as a video? Check out our YouTube Channel. https://www.youtube.com/@hiddenkillerspodInstagram https://www.instagram.com/hiddenkillerspod/Facebook https://www.facebook.com/hiddenkillerspod/Tik-Tok https://www.tiktok.com/@hiddenkillerspodX Twitter https://x.com/TrueCrimePodListen Ad-Free On Apple Podcasts Here: https://podcasts.apple.com/us/podcast/true-crime-today-premium-plus-ad-free-advance-episode/id1705422872This publication contains commentary and opinion based on publicly available information. All individuals are presumed innocent until proven guilty in a court of law. Nothing published here should be taken as a statement of fact, health or legal advice.
The Cathy Heller Podcast: A Podcast for Soulful Entrepreneurs
Cathy shares the two mindsets behind manifestation, how you can move out of lack and into wholeness, and how to create from overflow. - Get a one week trial of This Abundant Life for $1 cathyheller.com/gift
Forget the questionable relationship advice from internet influencers. Today, we're diving into the science of lasting love, fighting, and "red flags” to find out what really matters for a healthy relationship. We'll find out what it means to fight well with your partner. And we'll also look at the signs that a relationship might become dangerous or abusive. For all this, we speak with Professor Ben Karney, Dr. Megan Haselschwerdt, Dr. Elizabeth McLindon and Matt Brown. U.S. National Domestic Violence Hotline: 800.799.7233 or www.thehotline.org Find international resources and more at spotify.com/resources Find our transcript here: https://bit.ly/ScienceVsIsYourRelationshipOK In this episode, we cover: (00:00) Influencers love giving advice (02:36) How to have a ‘healthy fight' (09:44) If you fight badly, will you get divorced? (13:55) What are ‘red flags'? (21:01) Red flags you should watch for (28:23) Approaches to try to change abusive partners (34:00) Why do people try to control their partners? (37:57) Can an abusive partner change? This episode was produced by Wendy Zukerman, with help from Michelle Dang, Meryl Horn, Rose Rimler, and Ekedi Fausther-Keeys. We're edited by Blythe Terrell. Fact checking by Diane Kelly. Mix and sound design by Bobby Lord. Music written by Emma Munger, So Wylie, Peter Leonard, Bumi Hidaka and Bobby Lord. Thanks to our consultants Maya Serelis and Jess Hill. A special thanks to the researchers and folks working in the space of domestic violence that we spoke to including, Dr Áine Travers, Claire Marshall, Professor Sharon Dawe, Professor Kelsey Hegarty, Dr Franscesca Righetti, Dr Andrea Meltzer, Professor Amy Rauer, and Dr Amie Zarling. A big thanks to Joseph Lavelle Wilson and the Zukerman family. Science Vs is a Spotify Studios Original. Listen for free on Spotify or wherever you get your podcasts. Follow us and tap the bell for episode notifications. Learn more about your ad choices. Visit podcastchoices.com/adchoices
Guest: Simon Constable. As Storm Nills approaches France, Constable reports on rising copper prices and volatile gold, while noting UK PM Starmer faces severe political pressure from opposition parties.MONET
© 2020-2026 Ivy Podcast Discovery LLC
